You are here

brolucizumab

Novartis’ new eye drug undercuts Bayer’s rival with fewer injections

Pharmaforum

Tue, 10/8/19 - 09:27 am

wet age-related macular degeneration

Novartis backs brolucizumab with new head-to-head Eylea trial

Pharmaforum

Mon, 09/9/19 - 08:15 pm

clinical trials

age-related macular degeneration

3 Drugs Under FDA Review With Blockbuster Potential

Motley Fool

Fri, 06/21/19 - 11:24 am

rheumatoid arthritis

wet age-related macular degeneration

relapsing multiple sclerosis

FDA accepts BLA for Novartis' AMD therapy

BioCentury

Mon, 04/15/19 - 11:31 pm

wet age-related macular degeneration

5 Experimental New Drugs That Could Be Worth $47 Billion

Motley Fool

Wed, 06/20/18 - 09:26 am

VX-659 + tezacaftor + ivacaftor

Vertex Pharmaceuticals